Earnings Feed
Start Free
|4Feb 20, 5:20 PM ET

Pauwels Eric 4

Research Summary

AI-generated summary

Updated

PTC Therapeutics (PTCT) CBO Eric Pauwels Sells 3,019 Shares

What Happened

Eric Pauwels, Chief Business Officer of PTC Therapeutics (PTCT), disposed of 3,019 shares on February 18, 2026 at $69.36 per share, netting approximately $209,398. The sale was an automatic sell-to-cover to satisfy tax withholding obligations tied to RSU vesting, not an independent open-market trade intended as a bet on the stock.

Key Details

  • Transaction date & price: 2026-02-18, 3,019 shares at $69.36 each; total proceeds ≈ $209,398.
  • Type: Sale (S) — reported as open market/private sale; executed automatically as sell-to-cover.
  • Reason (footnote): Shares were sold pursuant to an irrevocable sell-to-cover election to satisfy tax withholding for vesting of RSUs — 5,500 RSUs (from a 22,000 RSU grant dated Feb 15, 2024) and 1,150 RSUs (from a 2,300 RSU grant dated Feb 15, 2024).
  • Filing: Report filed 2026-02-20 for a 2026-02-18 transaction — appears timely (filed within two business days).

Context

Sell-to-cover transactions are routine tax-withholding actions when restricted stock units vest; they generally do not signal a change in an insider’s view of the company. This was not an exercise of options or a gift; it was an automatic sale to cover taxes associated with vested RSUs.